(HealthDay News) — A gap persists between the need for and receipt of substance use disorder (SUD) treatment among U.S. individuals, according to a research letter published online Jan. 6 in JAMA ...

People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug ...

Purdue Pharma and the Sackler family that controls the major prescription opioids manufacturer have agreed to a $7.4 billion settlement with West Virginia and 13 other states due to fueling the ...

Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...

Medical users are as likely or more likely to develop cannabis use disorder as recreational users They also tend to use weed ...

A new study conducted by University of California San Francisco researchers found buprenorphine works for treating opioid use ...

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...